Abatacept


( Last Updated : November 29, 2012)
Generic Name:
Abatacept
Project Status:
Complete
Therapeutic Area:
Arthritis, rheumatoid
Manufacturer:
Bristol-Myers Squibb Canada
Call for patient/clinician input open:
Brand Name:
Orencia
Project Line:
Reimbursement Review
Project Number:
SR0299-000
Call for patient/clinician input closed:
NOC Status at Filing:
Pre NOC

Details


Submission Type:
Initial
Indications:
Arthritis, Rheumatoid
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation: